11C-Fallypride: Radiosynthesis and preliminary evaluation of a novel dopamine D2/D3 receptor PET radiotracer in non-human primate brain

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 1, 2004, Pages 95-102

  Mukherjee, Jogeshwar ^a   Shi, Bingzhi ^b   Christian, Bradley T ^b   Chattopadhyay, Sankha ^a   Narayanan, Tanjore K ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR BLOCKING AGENT; FALLYPRIDE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; CARBON; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; N ((1 ALLYL 2 PYRROLIDINYL)METHYL) 5 (3 FLUOROPROPYL) 2,3 DIMETHOXYBENZAMIDE; N-((1-ALLYL-2-PYRROLIDINYL)METHYL)-5-(3-FLUOROPROPYL)-2,3-DIMETHOXYBENZAMIDE; PYRROLIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN CORTEX; BRAIN REGION; CAUDATE NUCLEUS; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOPAMINERGIC NERVE CELL; DRUG SYNTHESIS; ISOTOPE LABELING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PUTAMEN; THALAMUS; ANIMAL; ARTICLE; BRAIN; CHEMISTRY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG ANTAGONISM; DRUG SCREENING; MACACA; METABOLISM; METHODOLOGY; SCINTISCANNING;

PRIMATES;

ANIMALS; BENZAMIDES; BRAIN; CARBON RADIOISOTOPES; DOPAMINE ANTAGONISTS; DRUG EVALUATION, PRECLINICAL; MACACA MULATTA; PYRROLIDINES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0346040465     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2003.10.020     Document Type: Conference Paper

References (11)

1. Mukherjee J., Christian B.T., Dunigan K., Shi B., Narayanan T.K., Satter M., Mantil J. Synapse. 46:2002;170.
2. Christian B.T., Shi B., Narayanan T.K., Mukherjee J. Synapse. 38:2000;71.
3. Mukherjee J., Yang Z.Y., Lew R., Brown T., Kronmal S., Cooper M., Seiden L.S. Synapse. 27:1997;1.
4. Christian B., Narayanan T., Shi B., Metz J., Mukherjee J. Soc. Neurosci. Abstr. 27:2001;774. 4.
5. Ehrin E., Gawell L., Hogberg T., de Paulis T., Strom P. J. Labeled Compd. Radiopharm. 24:1987;931.
6. Halldin C., Farde L., Hogberg T., Mohell N., Hall H., Suhara T., Karlsson P., Nakashima Y., Swahn C.-G. J. Nucl. Med. 36:1995;1275.
7. Bishop J.E., Mathis C.A., Gerdes J.M., Whitney J.M., Eaton A.M., Mailman R.B. J. Med. Chem. 34:1991;1612.
8. Mukherjee J., Yang Z.Y., Das M.K., Brown T. Nucl. Med. Biol. 22:1995;283.
9. Mukherjee J. J. Fluorine Chem. 49:1990;151.
10. Shi B., Narayanan T.K., Mattmuller S., Carone M., Mukherjee J. J. Nucl. Med. 42(Suppl. 5):2001;1121.
11. Lundkvist C., Sandell J., Nagren K., Pike V.W., Halldin C. J. Labeled Compd. Radiopharm. 41:1998;545.